Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05912634

Repair Versus Non-repair of the Aortic Arch in Type A Aortic Dissection

Acute Stanford type A aortic dissection (TAAD) is a life-threatening clinical status requiring surgery that is usually performed as a salvage procedure.We planned a multicenter study to evaluate the balance between the patient's condition and those therapeutic strategies that may limit the risk of late adverse events in patients who will be underwent surgery for appropriate management of TAAD

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Aortic Dissection Acute Aortic Syndrome Aneurysm Aortic Arch Aortic Dilatation Aortic Diseases Aortic Dissection Rupture Cardiovascular Diseases Dissection, Blood Vessel Vascular Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Francesco Nappi

Saint-Denis, France, 93200

About this study

Substantial evidence has suggested a decrease of early mortality during the last years, however recently the Nordic Consortium for Acute Type A Aortic Dissection registry recorded 18% of 30-day mortality after surgery for ATAAD. Similarly, the prospective German Registry for Acute Aortic Dissection Type A confirmed this data reporting a 30-day mortality of 16.9%. Again, results from recent analysis of the Society of Thoracic Surgeon database that report 7353 procedures from 2014 and 2017 for acute TAAD revealed a 30-day mortality of 17%. Understanding the balance between the patient's conditions which may not allow extensive procedure and those treatment strategies which may limit the risk of late adverse events in patients who remain alive long after the surgery is essential for an appropriate management of ATAAD. The best treatment option in patients with ATAAD is dictated by the balance between patient conditions that may not allow for extensive procedures and those more conservative treatment strategies that limit the risk of late adverse events in patients who remain alive long after surgery. surgery. However, previous evidence from large series of patients do not provide information on the long-term durability of these procedures.

Here investigators planned a multicenter study to evaluate the contemporary early outcomes and duration of different surgical strategies for 15-year acute ATAAD in a large study population.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged > 18 years
  • TAAD or intramural hematoma involving the ascending aorta
  • Symptoms started within 7 days from surgery
  • Primary surgical repair of acute TAAD
  • Any other major cardiac surgical procedure concomitant with surgery for TAAD.

Exclusion criteria

  • Patients aged < 18 years
  • Onset of symptoms > 7 days from surgery
  • Prior procedure for TAAD
  • Concomitant endocarditis;
  • TAAD secondary to blunt or penetrating chest trauma.

Treatment and study plan

Conservative TAAD-R

Procedure

Cardiac arrest will be ensured using antegrade potassium-rich cardioplegia solution delivered directly into the coronary ostium or after coronary sinus cannula insertion, in patients with aortic regurgitation aorta will be resected down to the sinotubular junction and the thrombus located in the false lumen of the aortic root will be removed so that the aortic lesion could be visualized. The commissures will be resuspended using 4-0 or 5-0 sutures reinforced with a Teflon pledget over each commissure. A 4-0 or 5-0 polypropylene suture will be chosen to seal the proximal anastomosis and this suture line will also be used to secure the intima to the adventitia. In patients revealing normal-sized aortic roots associated with poor-quality valve leaflets, concomitant aortic valve replacement with conventional xenograft or mechanical prosthesis will be preferred.

Other names: Ascending Aortic Root Sparing Replacement with or without Hemiarch Repair

Extensive TAAD- R

Procedure

Patients who experienced dilatation of the sinuses of Valsalva >4.5 cm in diameter on computed tomography imaging, those with connective tissue disease, or those in whom intimal tears extended into the sinuses, will undergoing replacement of the aortic root using a biologic or mechanical composite valve graft or valve-sparing root reimplantation procedure.Total arch replacement procedures (TARP) will fulfilled with the use of deep hypothermic circulatory arrest and with either antegrade or retrograde cerebral perfusion, maintaining systemic cooling between 19°C to 25°C and depending on the surgeon's practice.TARPs will be carried out using 1- and 4-branch grafts and involved the resection of all the aortic tissue up to the left common carotid artery (total arch)

Other names: Aortic root procedures.TARP procedures. Frozen Elephant Trunk (FET) procedure

Primary outcomes

  1. Operative Mortality (OM)

    Time frame: 30-day

    Patients who died within 30 days

  2. Rate of acute heart failure

    Time frame: 30-day

    Number of participants with postoperative heart failure who will require prolonged use of concentration of inotropes for a period greater than 24 h and/or the insertion of any mechanical circulatory support device.

  3. Stroke

    Time frame: 30-day

    Number of participants with acute episode of a focal or global neurological deficit. Rates of alteration of degree of consciousness, hemiplegia, hemiparesis, numbness or sensory loss affecting one side of the body, dysphasia or aphasia, hemianopsia, amaurosis fugax. To consider rate of other neurologic signs or symptoms consistent with stroke duration of focal or global neurologic deficit greater than 24 hours.

  4. Rate of global brain ischemia

    Time frame: 30-days

    Rate of diffuse hypoxic damage as diagnosed at brain imaging and electroencephalography.

  5. Rate of mesenteric ischemia

    Time frame: 30-days

    Rate of abdominal pain with or without nausea and vomiting and rectal bleeding or bloody diarrhea

  6. Rate of acute kidney injury

    Time frame: 30-days

    Number of participants with postoperative change in serum creatinine concentration. Severity will be stratified on the basis of number of participants with the KDIGO (Kney Disease Improving Global Outcomes) criteria.

Secondary outcomes

  1. Rate of paraplegia/paraparesis

    Time frame: 30-day

    Rate of bilateral weakness and/or multimodality sensory disturb- ance below the level of the ischemic spinal lesion.

  2. Rate of perioperative bleeding

    Time frame: 30-day

    Number of participants will receive postoprative transfused red blood cell units. The E-CABG ( coronary artery by pass grafting) classification of bleeding rate has been proposed as a simple classification of perioperative bleeding

  3. Rate of reoperation for bleeding

    Time frame: 30-day

    Number of participants who will receive postoperative chest reopening for excessive bleeding.

  4. Rate of mechanical circulatory support

    Time frame: 30-day

    Number of participants who will receive the use of intra-aortic balloon pump and/or venoarterial extracorporeal membrane oxygenation for postoperative acute heart failure.

  5. Late outcomes

    Time frame: 18 years

    Data on patient's survival status will be collected

Other outcomes

  1. Rate of urgent procedure

    Time frame: 30-days

    Number of participants who will require scheduled procedure within 24 hours of admission.

  2. Rate of emergency grade 1

    Time frame: 30-days

    Number of participants will require procedure within 24 hours of hospital admission and who are symptomatic or minimally symptomatic with stable hemodynamic conditions and no signs of malperfusion.

  3. Rate of emergency grade 2

    Time frame: 30-days

    Number of participants who will require procedure within the first 6 hours of hospital admission due to hemodynamic instability despite use of concentration inotropes and/or malperfusion.

  4. Rate of salvage grade 1

    Time frame: 30-days

    Number of participants who will require immediate surgical procedure. Rate of cardio pulmonary resuscitation with external chest compressions and/or open cardiac massage between induction of anesthesia and initiation of cardiopulmonary bypass.

  5. Rate of salvage grade 2

    Time frame: 30-days

    Number of participants who will require immediate surgical procedure. Rate of cardiopulmonary resuscitation with external chest compressions en route to the operating theatre or prior to induction of anesthesia.

Sponsors and collaborators

Lead sponsor

Centre Cardiologique du Nord

Other

Collaborators

  • Henri Mondor University Hospital
  • Pitié-Salpêtrière Hospital
  • Universita degli Studi di Genova

Registry information

Official study title

Early Complication and Outcomes in Surgical vs no Surgical Involvement of Aortic Arch in Type A Aortic Dissection

Acronym: AoArch

Important dates

Study start
2014
Primary completion
2025
Study completion
2026
First posted
Jun 22, 2023
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.